Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00161655
Status:
COMPLETED
Last Update Posted:
2009-09-28
First Post:
2005-09-08
Brief Title:
Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Study Overview
Official Title:
A Multicenter Open-label Randomized Pilot-study to Evaluate the Efficacy and Safety of the Combination of Etanercept ETN and Methotrexate and of Etanercept ETN Alone in Patients With Plaque Psoriasis Despite Methotrexate Therapy
Status:
COMPLETED
Status Verified Date:
2009-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy to clear or almost clear the plaques in plaque psoriasis patients treated with the combination etanercept and methotrexate compared to etanercept alone
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None